Form4insider filings, from the source

SEC Form 4 · accession 0000899243-17-000987

Mirati Therapeutics, Inc. · MRTX

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners
Joseph Lewis
10% Owner
Neil Reisman
10% Owner
Period of report
Jan 6, 2017
Accepted (ET)
Jan 10, 2017 · 5:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001576263

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Jan 6, 2017P280,059$5.60A1,037,994D
Common StockF3Jan 6, 2017P6,104$5.60A435,444D
Common StockF4holding———30,518D
Common StockF5holding———13,131D
Common StockF6holding———37,241D
Common StockF7holding———77,038D
Common StockF8holding———87,052D

Table II — derivative securities

SecurityConv. / exercise priceDateCodeSharesA/DExercisableExpiresUnderlyingUnderlying sharesOwned afterD/I
Warrant (right to purchase)F1,F2,F9$0.001Jan 6, 2017P2,341,786AJan 6, 2017—Common Stock2,341,7862,341,786D
Warrant (right to purchase)F3,F9$0.001Jan 6, 2017P51,047AJan 6, 2017—Common Stock51,04751,047D

Explanation of responses